SolasCure publishes phase IIa clinical trial report in leading wound care journal Post author: Post published: March 4, 2024 Post category:uncategorized Study demonstrates proof-of-concept and strong safety profile of Aurase Wound Gel in patients suffering from chronic wounds. You Might Also Like Late-night snacking may affect liver health October 9, 2026 Study suggests maternal adverse childhood experiences may become biologically embedded August 13, 2024 Breakthrough dual-drug hydrogel promotes cartilage repair in osteoarthritis July 3, 2025
Study suggests maternal adverse childhood experiences may become biologically embedded August 13, 2024